The pharmacology of CGRP-responsive receptors in cultured and transfected cells
- 10 July 2004
- Vol. 25 (11) , 2019-2026
- https://doi.org/10.1016/j.peptides.2004.06.007
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Comparison of the expression of calcitonin receptor‐like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell linesBritish Journal of Pharmacology, 2002
- Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cellsEuropean Journal of Pharmacology, 2001
- Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteriesEuropean Journal of Pharmacology, 2001
- CGRP and adrenomedullin binding correlates with transcript levels for Calcitonin Receptor‐Like Receptor (CRLR) and Receptor Activity Modifying Proteins (RAMPs) in rat tissuesBritish Journal of Pharmacology, 2000
- Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonistBritish Journal of Pharmacology, 2000
- Multiple Amylin Receptors Arise from Receptor Activity-Modifying Protein Interaction with the Calcitonin Receptor Gene ProductMolecular Pharmacology, 1999
- A Receptor Activity Modifying Protein (RAMP)2-Dependent Adrenomedullin Receptor Is a Calcitonin Gene-Related Peptide Receptor when Coexpressed with Human RAMP1Endocrinology, 1999
- A rat skeletal muscle cell line (L6) expresses specific adrenomedullin binding sites but activates adenylate cyclase via calcitonin gene-related peptide receptorsBiochemical Journal, 1996
- A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 ReceptorJournal of Biological Chemistry, 1996
- Calcitonin gene‐related peptide receptors in human gastrointestinal epitheliaBritish Journal of Pharmacology, 1994